Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.

Paryani, S G; Arvin, A M; Koropchak, C M; Wittek, A E; Amylon, M D; Dobkin, M B; Budinger, M D

Paryani, S G; Arvin, A M; Koropchak, C M; Wittek, A E; Amylon, M D; Dobkin, M B; Budinger, M D.

Am J Med ; 76(3A): 124-7, 1984 Mar 30.

Article in En | MEDLINE | ID: mdl-6324585

ABSTRACT

ABSTRACT

Varicella is a serious infection in the immunocompromised patient. Prophylaxis with varicella zoster immune globulin is known to decrease the incidence of severe varicella infection. The titers of antibody to varicella zoster virus were compared in patients who received either varicella zoster immune globulin or intravenous immune globulin, 4 ml or 6 ml/kg per dose. The titers of antibody to varicella zoster virus were comparable in each group.

Subject(s)

Antibodies, Viral/biosynthesis; Herpes Zoster/therapy; Immune Sera/administration & dosage; Immunoglobulin G/analogs & derivatives; Adolescent; Agammaglobulinemia/complications; Child; Child, Preschool; Dose-Response Relationship, Immunologic; Herpes Zoster/etiology; Herpes Zoster/immunology; Herpesvirus 3, Human/immunology; Humans; Immune Sera/immunology; Immunoglobulin G/administration & dosage; Immunoglobulin G/immunology; Immunoglobulin G/metabolism; Immunoglobulins, Intravenous; Infusions, Parenteral/adverse effects

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G / Herpes Zoster / Immune Sera / Antibodies, Viral Type of study: Etiology_studies Limits: Adolescent / Child / Child, preschool / Humans Language: En Journal: Am J Med Year: 1984 Type: Article

Search on Google

XML

PubMed Links